Photobiomodulation therapy combined with radiotherapy in the treatment of triple-negative breast cancer-bearing mice.
J Photochem Photobiol B. 2021 May 17 ;220:112215. Epub 2021 May 17. PMID: 34029847
Camila Ramos Silva
This work investigated the effect of photobiomodulation therapy (PBM) combined with radiotherapy (RT) on triple-negative breast cancer (TNBC)-bearing mice. Female BALB/c mice received 4 T1 cells into a mammary fat pad. Local RT was performed with a total dose of 60 Gy divided into 4 consecutive sessions of 15 Gy. For PBM, a red laser was used in three different protocols: i-) single exposure delivering 150 J.cm(24 h after the last RT session), and ii-) radiant exposure of 150 J.cmor iii-) fractionated radiant exposure of 37.5 J.cm(after each RT session). Tumor volume, complete blood cell count, clinical condition, metastasis, and survival of animals were monitored during 3 weeks post-RT. Our results demonstrated that regardless of the protocol, PBM arrested the tumor growth, improved the clinical condition, and prevented hemolytic anemia. Besides, although PBM groups have exhibited a high neutrophil:lymphocyte ratio (NLR), they decreased the number of lung metastases and enhanced mouse survival. Worthy of note, PBM should be used along with the RT sessions in higher radiant exposures, since PBM at 150 J.cmper session significantly extended the survival rate. Together, these data suggest PBM could be a potential ally to RT to fight TNBC.